| CD44: structure, function and association with the malignant process D Naor, RV Sionov, D Ish-Shalom Advances in cancer research 71, 241-319, 1997 | 1325 | 1997 |
| CD44 in cancer D Naor, S Nedvetzki, I Golan, L Melnik, Y Faitelson Critical reviews in clinical laboratory sciences 39 (6), 527-579, 2002 | 744 | 2002 |
| CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow A Avigdor, P Goichberg, S Shivtiel, A Dar, A Peled, S Samira, O Kollet, ... Blood 103 (8), 2981-2989, 2004 | 641 | 2004 |
| Involvement of CD44, a molecule with a thousand faces, in cancer dissemination D Naor, SB Wallach-Dayan, MA Zahalka, RV Sionov Hyaluronan in Cancer Biology, 127-146, 2009 | 427 | 2009 |
| RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy S Nedvetzki, E Gonen, N Assayag, R Reich, RO Williams, RL Thurmond, ... Proceedings of the National Academy of Sciences 101 (52), 18081-18086, 2004 | 269 | 2004 |
| Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor D Ish-Shalom, CT Christoffersen, P Vorwerk, N Sacerdoti-Sierra, ... Diabetologia 40, S25-S31, 1997 | 244 | 1997 |
| Suppressor cells: permitters and promoters of malignancy? D Naor Advances in Cancer Research 29, 45-125, 1979 | 241 | 1979 |
| Immunological and autoimmune considerations of Autism Spectrum Disorders B Gesundheit, JP Rosenzweig, D Naor, B Lerer, DA Zachor, V Procházka, ... Journal of autoimmunity 44, 1-7, 2013 | 227 | 2013 |
| Binding of radioiodinated bovine serum albumin to mouse spleen cells D Naor, D Sulitzneau Nature 214 (5089), 687-688, 1967 | 190 | 1967 |
| Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody L Weiss, S Slavin, S Reich, P Cohen, S Shuster, R Stern, E Kaganovsky, ... Proceedings of the National Academy of Sciences 97 (1), 285-290, 2000 | 149 | 2000 |
| CD44 in rheumatoid arthritis D Naor, S Nedvetzki Arthritis Res Ther 5, 1-11, 2003 | 143 | 2003 |
| The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation L Eshkar Sebban, D Ronen, D Levartovsky, O Elkayam, D Caspi, S Aamar, ... The Journal of Immunology 179 (2), 1225-1235, 2007 | 138 | 2007 |
| Lymph node (but not spleen) invasion by murine lymphoma is both CD44-and hyaluronate-dependent. MA Zahalka, E Okon, U Gosslar, B Holzmann, D Naor Journal of immunology (Baltimore, Md.: 1950) 154 (10), 5345-5355, 1995 | 135 | 1995 |
| MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization Y Vagima, A Avigdor, P Goichberg, S Shivtiel, M Tesio, A Kalinkovich, ... The Journal of clinical investigation 119 (3), 492-503, 2009 | 118 | 2009 |
| CD44 involvement in experimental collagen-induced arthritis (CIA) S Nedvetzki, M Walmsley, E Alpert, RO Williams, M Feldmann, D Naor Journal of autoimmunity 13 (1), 39-47, 1999 | 99 | 1999 |
| CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44‐targeting by antibody or from knockout mice D Naor, S Nedvetzki, M Walmsley, A Yayon, EA Turley, I Golan, D Caspi, ... Annals of the New York Academy of Sciences 1110 (1), 233-247, 2007 | 84 | 2007 |
| Autoimmunity and aging: the age-related response of mice of a long-lived strain to trinitrophenylated syngeneic mouse red blood cells D Naor, B Bonavida, RL Walford The Journal of Immunology 117 (6), 2204-2208, 1976 | 83 | 1976 |
| Regulatory T-cells in Graves' orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin GJ Kahaly, O Shimony, YN Gellman, SD Lytton, L Eshkar-Sebban, ... The Journal of Clinical Endocrinology & Metabolism 96 (2), 422-429, 2011 | 77 | 2011 |
| Induction of immune responsiveness in a genetically low‐responsive tumor‐host combination by chemical modification of the immunogen N Galili, D Naor, B Åsjö, G Klein European Journal of Immunology 6 (7), 473-476, 1976 | 74 | 1976 |
| interaction between hyaluronic acid and its receptors (CD44, RHAMM) regulates the activity of inflammation and cancer D Naor Frontiers in Immunology 7, 39, 2016 | 72 | 2016 |
